Showing results (361-370 of 1,062) with videos related to

Sort By:
Pageof 107
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Measuring cognition and function in the preclinical stage of Alzheimer's diseaseSandra Weintraub, Maria C Carrillo, Sarah Tomaszewski Farias, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Wishes and preferences for an online lifestyle program for brain health-A mixed methods studyLinda M P Wesselman, Ann-Katrin Schild, Nina Coll-Padros, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Alzheimer's disease drug development pipeline: 2018Jeffrey Cummings, Garam Lee, Aaron Ritter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 30, 2018
Neural correlates of episodic memory in the Memento cohortStephane Epelbaum, Vincent Bouteloup, Jean F Mangin, et al.
Alzheimer'S & Dementia (New York, N. Y.)|May 9, 2017
The Effect of Statins on Rate of Cognitive Decline in Mild Cognitive ImpairmentKyle B Smith, Paul Kang, Marwan N Sabbagh, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Body brain life: A randomized controlled trial of an online dementia risk reduction intervention in middle-aged adults at risk of Alzheimer's diseaseKaarin J Anstey, Alex Bahar-Fuchs, Pushpani Herath, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Is late-onset Alzheimer's disease really a disease of midlife?Karen Ritchie, Craig W Ritchie, Kristine Yaffe, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
Alzheimer's disease assessment scale-cognitive 11-item progression model in mild-to-moderate Alzheimer's disease trials of bapineuzumabMahesh N Samtani, Steven X Xu, Alberto Russu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 2, 2018
A phase 1 study to evaluate the safety and pharmacokinetics of PQ912, a glutaminyl cyclase inhibitor, in healthy subjectsInge Lues, Frank Weber, Antje Meyer, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 19, 2020
Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairmentEric E Smith, Philip Barber, Thalia S Field, et al.
Pageof 107